Tonix Pharmaceuticals Holding Cash Flow Statement (2010-2026) | TNXP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Sep2016 Dec2016 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-23.58M-18.67M-29.71M-26.57M-24.15M-29.14M-31.83M-33.14M-29.14M-29.23M-26.80M-23.14M-78.89M-16.90M-22.55M-15.78M-28.34M-31.87M-46.82M-40.34M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
2.09M2.30M2.30M0.04M2.81M2.77M2.72M0.03M2.36M2.08M2.04M1.69M1.15M1.04M0.89M0.88M1.42M1.92M1.79M1.97M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
-7.00M0.85M
Asset Writedowns and Impairment (Quarter)
58.96M0.30M-57.47M-0.10M-0.65M
Cash from Operations (Quarter)
-19.11M-12.95M-22.45M-31.05M-21.17M-23.54M-22.30M-32.91M-23.37M-23.39M-22.34M-17.57M-9.92M-18.80M-14.63M-16.58M-14.83M-28.78M-39.65M-42.32M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.30M0.13M0.21M0.20M0.07M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.03M0.06M0.10M0.25M0.84M0.89M0.90M1.22M1.26M1.21M1.21M0.51M0.50M0.49M0.48M0.46M0.49M0.56M
Change in Working Capital
Change in Receivables (Quarter)
1.64M-1.30M-0.37M-0.99M1.19M2.79M2.55M
Change in Inventory (Quarter)
-1.29M-1.16M-1.25M-0.05M-0.27M0.13M-1.22M-0.36M-2.37M
Change in Account Payables (Quarter)
0.55M4.56M0.16M-3.11M1.55M-2.52M3.03M0.57M-1.15M1.02M-3.94M2.98M3.73M-6.36M0.58M-0.35M3.06M1.02M-0.74M1.53M
Change in Accured Expenses (Quarter)
1.43M-0.73M2.90M-2.03M-0.28M1.31M2.21M-2.96M1.36M-1.05M4.43M-1.75M0.91M0.47M1.55M-2.95M3.36M1.25M10.08M-2.06M
Other Working Capital Changes (Quarter)
-0.01M0.01M-0.00M-0.00M0.00M0.00M-0.00M-0.01M0.01M0.02M0.01M0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.28M0.08M
Investing Activities
Capital Expenditures (Quarter)
1.43M7.75M25.62M20.22M14.44M8.82M4.67M0.36M0.80M-0.89M7.62M0.11M0.01M0.00M0.01M0.52M0.97M1.87M1.69M
Sales of Property, Plant and Equipment (Quarter)
0.01M
Acquisitions (Quarter)
22.17M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-1.43M-7.75M-25.62M-20.22M-14.44M-8.82M-4.67M-3.80M-24.02M-0.82M-0.43M-0.11M-0.01M-0.00M-0.01M-2.54M-0.96M-1.02M-1.69M
Financing Activities
Other financing activities (Quarter)
-0.03M0.09M-0.09M0.04M0.03M0.02M0.00M0.08M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
0.23M0.70M0.70M0.70M9.65M
Change in Capital Stock
Shares Issued (Quarter)
16.09M25.78M0.10M11.15M2.47M0.53M435.000.89M1.39M0.25M774.000.57M0.02M0.36M0.00M0.00M0.00M0.00M1.15M0.24M
Net Equity Issued and Repurchased (Quarter)
22.05M37.89M43.77M13.02M-30.71M13.35M2.44M1.03M6.27M9.20M43.61M85.86M62.23M13.89M94.86M66.95M20.13M
Misc.
Cash from Financing Activities (Quarter)
22.05M37.96M43.77M13.06M72.18M-4.62M7.23M-11.50M1.03M6.27M40.71M-0.21M7.03M42.91M85.15M49.53M10.99M94.86M59.14M20.20M
Exchange Rate Effect (Quarter)
-0.01M-0.01M-0.01M-0.03M-0.02M-0.02M-0.01M-0.04M-0.01M-0.01M-0.00M0.00M-0.02M0.02M-0.01M-0.00M-0.00M-0.01M0.01M
Change in Cash (Quarter)
1.50M17.25M-4.31M-38.23M36.54M-37.00M-19.75M-48.25M-46.36M-17.94M17.93M-17.90M-2.89M24.08M70.55M32.94M-6.38M65.11M18.46M-23.80M
Free Cash Flow (Quarter)
-20.54M-20.70M-48.07M-51.26M-35.61M-32.35M-26.97M-33.27M-24.17M-22.50M-29.96M-17.68M-9.92M-18.81M-14.63M-16.59M-15.35M-29.75M-41.52M-44.01M
Net Cash Flow (Quarter)
1.51M17.26M-4.30M-38.20M36.57M-36.98M-19.74M-48.21M-46.36M-17.93M17.94M-17.89M-2.89M24.09M70.52M32.95M-6.38M65.12M18.47M-23.80M